This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

    More

    Page   1/1   
  • 2013 Financial Times Global Pharma/Biotech Conference
    Life sciences & health care collection spotlights Deloitte reports and involvement at Financial Times Global Pharmaceutical and Biotechnology Conference 2013.
  • Focus: FT Global Pharma & Biotech Conference 2012
    Life sciences & health care collection spotlights Deloitte reports and involvement at Financial Times Global Pharmaceutical and Biotechnology Conference 2012.
  • Life Sciences and Health Care in China
    This report provides a comprehensive overview of the life sciences and health care industry in China today.
  • Article
  • Opportunity and optimism
    Deloitte member firm public sector leaders from around the world share expectations, opportunities, optimism on the new U.S. administration led by President Barack Obama.
  • Page   1/1   

Deloitte RSS feed  Deloitte YouTube  Deloitte Google+  Deloitte Facebook  Deloitte LinkedIn  Deloitte Twitter 

© 2014. See legal for more information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. Please see deloitte.nl/about for a more detailed description of DTTL and its member firms.

In The Netherlands the services are provided by independent subsidiaries or affiliates of Deloitte Holding B.V., an entity which is registered with the trade register in The Netherlands under number 40346342.